REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/22/2025
Back to search
Official data from USPTO
BIOLOGIK JEFFREY GIBSON MD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
09/23/2025
Trademark type
Combined
Nice classes
3
Filing date
12/20/2017
Registration date
09/22/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/22/2020
Last transaction
09/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/15/2020
First use in commerce
02/15/2020
Drawing code
5
Owner type
16
Owner location
Miami, FL
Examiner
FRUM MILONE, MARCIE
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "BioLogik" with an accent over the letter "i" followed by the words "by Jeffrey Gibson MD".
Holders and representatives
Holders
RX Genesys LLC
Representatives
Afschineh Latifi TUCKER & LATIFI, LLP
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Non-medicated skincare preparationsanti-aging serumsskin moisturizersskin creamsskin cleanserseye lotionsskin energizing preparations in the nature of serumscreamstonersgels and lotions
Publications
History of USPTO decisions and trademark events.
38 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/18/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/17/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/17/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/13/2020
IUAF
USE AMENDMENT FILED
08/04/2020
EISU
TEAS STATEMENT OF USE RECEIVED
08/04/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/06/2020
EX3G
SOU EXTENSION 3 GRANTED
02/04/2020
EXT3
SOU EXTENSION 3 FILED
02/04/2020
EEXT
SOU TEAS EXTENSION RECEIVED
02/04/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/31/2019
EX2G
SOU EXTENSION 2 GRANTED
07/29/2019
EXT2
SOU EXTENSION 2 FILED
07/29/2019
EEXT
SOU TEAS EXTENSION RECEIVED
07/29/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/06/2019
EX1G
SOU EXTENSION 1 GRANTED
02/04/2019
EXT1
SOU EXTENSION 1 FILED
02/04/2019
EEXT
SOU TEAS EXTENSION RECEIVED
02/04/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/07/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/12/2018
PUBO
PUBLISHED FOR OPPOSITION
06/12/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/23/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/03/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
05/03/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/03/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
05/03/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/02/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/01/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/25/2018
GNRT
NON-FINAL ACTION E-MAILED
04/25/2018
CNRT
NON-FINAL ACTION WRITTEN
04/25/2018
DOCK
ASSIGNED TO EXAMINER
03/30/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2018
NWAP
NEW APPLICATION ENTERED
12/23/2017
Continuous trademark protection
Get notified about every new filing that threatens BIOLOGIK JEFFREY GIBSON MD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.